These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 28379281)

  • 1. Regression of Established Cardiac Fibrosis in Hypertensive Heart Disease.
    Weber KT; Sun Y; Gerling IC; Guntaka RV
    Am J Hypertens; 2017 Nov; 30(11):1049-1052. PubMed ID: 28379281
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical aspects of hypertensive myocardial fibrosis.
    Díez J; López B; González A; Querejeta R
    Curr Opin Cardiol; 2001 Nov; 16(6):328-35. PubMed ID: 11704701
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting the Cardiac Myofibroblast Secretome to Treat Myocardial Fibrosis in Heart Failure.
    Weber KT; Díez J
    Circ Heart Fail; 2016 Aug; 9(8):. PubMed ID: 27470499
    [No Abstract]   [Full Text] [Related]  

  • 4. Cardiac Fibrosis: The Fibroblast Awakens.
    Travers JG; Kamal FA; Robbins J; Yutzey KE; Blaxall BC
    Circ Res; 2016 Mar; 118(6):1021-40. PubMed ID: 26987915
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A primer on current progress in cardiac fibrosis.
    Al Hattab D; Czubryt MP
    Can J Physiol Pharmacol; 2017 Oct; 95(10):1091-1099. PubMed ID: 28273426
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potential reduction of interstitial myocardial fibrosis with renal denervation.
    Doltra A; Messroghli D; Stawowy P; Hassel JH; Gebker R; Leppänen O; Gräfe M; Schneeweis C; Schnackenburg B; Fleck E; Kelle S
    J Am Heart Assoc; 2014 Dec; 3(6):e001353. PubMed ID: 25516438
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tetrandrine reverses human cardiac myofibroblast activation and myocardial fibrosis.
    Teng G; Svystonyuk D; Mewhort HE; Turnbull JD; Belke DD; Duff HJ; Fedak PW
    Am J Physiol Heart Circ Physiol; 2015 Jun; 308(12):H1564-74. PubMed ID: 25862829
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of rosuvastatin on cardiac remodeling, function, and progression to heart failure in hypertensive heart with established left ventricular hypertrophy.
    Chang SA; Kim YJ; Lee HW; Kim DH; Kim HK; Chang HJ; Sohn DW; Oh BH; Park YB
    Hypertension; 2009 Sep; 54(3):591-7. PubMed ID: 19564547
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Altered fibrillar collagen metabolism in hypertensive heart failure. Current understanding and future prospects].
    López Salazar B; Ravassa Albéniz S; Arias Guedón T; González Miqueo A; Querejeta R; Díez Martínez J
    Rev Esp Cardiol; 2006 Oct; 59(10):1047-57. PubMed ID: 17125715
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Employing Extracellular Volume Cardiovascular Magnetic Resonance Measures of Myocardial Fibrosis to Foster Novel Therapeutics.
    Schelbert EB; Sabbah HN; Butler J; Gheorghiade M
    Circ Cardiovasc Imaging; 2017 Jun; 10(6):. PubMed ID: 28512159
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PARP inhibition delays transition of hypertensive cardiopathy to heart failure in spontaneously hypertensive rats.
    Bartha E; Solti I; Kereskai L; Lantos J; Plozer E; Magyar K; Szabados E; Kálai T; Hideg K; Halmosi R; Sumegi B; Toth K
    Cardiovasc Res; 2009 Aug; 83(3):501-10. PubMed ID: 19443425
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of cardiotrophin-1 with myocardial fibrosis in hypertensive patients with heart failure.
    López B; González A; Querejeta R; Larman M; Rábago G; Díez J
    Hypertension; 2014 Mar; 63(3):483-9. PubMed ID: 24366078
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transgenic expression of matrix metalloproteinase-1 inhibits myocardial fibrosis and prevents the transition to heart failure in a pressure overload mouse model.
    Foronjy RF; Sun J; Lemaitre V; D'Armiento JM
    Hypertens Res; 2008 Apr; 31(4):725-35. PubMed ID: 18633185
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiac fibrosis in the ageing heart: Contributors and mechanisms.
    Lu L; Guo J; Hua Y; Huang K; Magaye R; Cornell J; Kelly DJ; Reid C; Liew D; Zhou Y; Chen A; Xiao W; Fu Q; Wang BH
    Clin Exp Pharmacol Physiol; 2017 Dec; 44 Suppl 1():55-63. PubMed ID: 28316086
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of autophagy inhibits the conversion of cardiac fibroblasts to cardiac myofibroblasts.
    Gupta SS; Zeglinski MR; Rattan SG; Landry NM; Ghavami S; Wigle JT; Klonisch T; Halayko AJ; Dixon IM
    Oncotarget; 2016 Nov; 7(48):78516-78531. PubMed ID: 27705938
    [TBL] [Abstract][Full Text] [Related]  

  • 16. K(ATP) activation prevents progression of cardiac hypertrophy to failure induced by pressure overload via protecting endothelial function.
    Gao S; Long CL; Wang RH; Wang H
    Cardiovasc Res; 2009 Aug; 83(3):444-56. PubMed ID: 19304734
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnosis and treatment of myocardial fibrosis in hypertensive heart disease.
    Díez J
    Circ J; 2008; 72 Suppl A():A8-12. PubMed ID: 18772529
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel paradigm for heart failure with preserved ejection fraction: comorbidities drive myocardial dysfunction and remodeling through coronary microvascular endothelial inflammation.
    Paulus WJ; Tschöpe C
    J Am Coll Cardiol; 2013 Jul; 62(4):263-71. PubMed ID: 23684677
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Functional brown adipose tissue limits cardiomyocyte injury and adverse remodeling in catecholamine-induced cardiomyopathy.
    Thoonen R; Ernande L; Cheng J; Nagasaka Y; Yao V; Miranda-Bezerra A; Chen C; Chao W; Panagia M; Sosnovik DE; Puppala D; Armoundas AA; Hindle A; Bloch KD; Buys ES; Scherrer-Crosbie M
    J Mol Cell Cardiol; 2015 Jul; 84():202-11. PubMed ID: 25968336
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sodium nitrite improves hypertension-induced myocardial dysfunction by mechanisms involving cardiac S-nitrosylation.
    Neto-Neves EM; Pinheiro LC; Nogueira RC; Portella RL; Batista RI; Tanus-Santos JE
    J Mol Cell Cardiol; 2019 Sep; 134():40-50. PubMed ID: 31226341
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.